Men (n = 457)

Women (n = 110)

OR

95% CI

p-value

TB^#

TB (%)

Never (%)

101 (22%)

356 (78%)

18 (16%)

92 (84%)

1.45

0.83 - 2.52

0.18

Site of TB^#

PTB^# (%)

EPTB^# (%)

n = 101 31 (30%)

70 (70%)

n = 18 10 (55%)

8 (45%)

0.35

0.11 - 1.09

0.04

WHO^$ stage Worse (3, 4) (%)

Better (1, 2) (%)

419 (92%)

38 (8%)

77 (70%)

33 (30%)

4.72

2.8 - 8

<0.001

WHO functional class Bedridden (%)

Working/ambulatory (%)

122 (27%)

335 (73%)

27 (25%)

83 (75%)

1.12

0.6 - 1.8

0.65

Clinical features Asymptomatic (%)

TB^# (%)

Frailty/weight loss (%)

Neurological (%)

Others (%)^*

28 (6%)

101 (22%)

142 (31%)

90 (20%)

96 (21%)

30 (27%)

18 (16%)

15 (14%)

22 (20%)

25 (23%)

0.17 1.45 2.85 0.7796 0.70

0.09 - 0.30 0.83 - 2.52 1.6 - 5.0 0.46 - 1.3 0.43 - 1.16

<0.001 0.18

<0.001 0.32 0.17

Mean CD4³ (cells/dl)

<350 (%)

>350 (%)

425 (93%)

32 (7%)

100 (91%)

10 (9%)

1.33

1.63 - 2.8

0.45